Publications by authors named "Rebecca Pulk"

Claim this Profile
T
The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.
Julie A Womack, Micaela M Leblanc, Annette S Sager, Lauren N Zaets, Stephen A Maisto, Rebecca Pulk

AIDS Behav· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Therapeutic Escalation for Pediatric Patients Admitted for Inflammatory Bowel Disease Flares.
Danielle N Koubek, Rebecca A Pulk, Joseph V Rosano

J Pediatr Pharmacol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient care.
Farah Kidwai-Khan, Christopher T Rentsch, Rebecca Pulk, Charles Alcorn, Cynthia A Brandt

Front Big Data· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists leadership in a medication shortage response: Illustrative examples from a health system response to the COVID-19 crisis.
Mahmoud A Ammar, Lydia J Tran, Bryan McGill, Abdalla A Ammar, Phu Huynh, Rebecca A Pulk

J Am Coll Clin Pharm· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Integrated Approach to Deploy Panel-Based Pharmacogenetic Testing and Clinical Decision Support.
Rebecca A Pulk, Allen L Hsiao, Michael F Murray, Lisa Stump, Wade L Schulz

J Appl Lab Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.
Jacob McPadden, Frederick Warner, H Patrick Young, Nathan C Hurley, Rebecca A Pulk

PLoS One· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.
Jacob McPadden, Frederick Warner, H Patrick Young, Nathan C Hurley, Rebecca A Pulk

medRxiv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
Rebecca Ann Pulk, Molly Leber, Lydia Tran, Mahmoud Ammar, Nilesh Amin

Am J Health Syst Pharm· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.
Stephen G Gonsalves, Robert T Dirksen, Katrin Sangkuhl, Rebecca Pulk, Maria Alvarellos

Clin Pharmacol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Pharmacogenomic Reports: Insights from Patients and Clinicians.
Laney K Jones, Alanna Kulchak Rahm, Michael R Gionfriddo, Janet L Williams, Audrey L Fan, Rebecca A Pulk

Clin Transl Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing big data to provide better health at lower cost.
Laney K Jones, Rebecca Pulk, Michael R Gionfriddo, Michael A Evans, Dean Parry

Am J Health Syst Pharm· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
ProvenCare-Psoriasis: A disease management model to optimize care.
Michael R Gionfriddo, Rebecca A Pulk, Dev R Sahni, Sonal G Vijayanagar, Joseph J Chronowski

Dermatol Online J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multigene predictors of tacrolimus exposure in kidney transplant recipients.
Rebecca A Pulk, David S Schladt, William S Oetting, Weihua Guan, Ajay K Israni

Pharmacogenomics· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors.
Michael Siu, Richard Pastor, Wendy Liu, Kathy Barrett, Megan Berry, Rebecca Pulk

Bioorg Med Chem Lett· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1.
Christopher A Hurley, Wade S Blair, Richard J Bull, Christine Chang, Peter H Crackett, Rebecca Pulk

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2.
Mark Zak, Christopher A Hurley, Stuart I Ward, Philippe Bergeron, Kathy Barrett, Rebecca Pulk

J Med Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2.
Sharada Labadie, Peter S Dragovich, Kathy Barrett, Wade S Blair, Philippe Bergeron, Rebecca Pulk

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.
Mark Zak, Rohan Mendonca, Mercedesz Balazs, Kathy Barrett, Philippe Bergeron, Rebecca Pulk

J Med Chem· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.
Simon Mathieu, Stefan N Gradl, Li Ren, Zhaoyang Wen, Ignacio Aliagas, Rebecca Pulk

J Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new regulatory switch in a JAK protein kinase.
Vickie Tsui, Paul Gibbons, Mark Ultsch, Kyle Mortara, Christine Chang, Rebecca Pulk

Proteins· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).
Christopher W West, Marc Adler, Danny Arnaiz, Deborah Chen, Kieu Chu, Rebecca Pulk

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.
Ignacio Aliagas-Martin, Dan Burdick, Laura Corson, Jennafer Dotson, Jason Drummond, Rebecca Pulk

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential inhibition of inducible T cell cytokine secretion by potent iron chelators.
Stewart Leung, April Holbrook, Beverly King, Hong-Tao Lu, Vincent Evans, Rebecca Pulk

J Biomol Screen· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis